{"id":"NCT00619918","sponsor":"Children's Hospital Los Angeles","briefTitle":"Nebulized Hypertonic Saline for Bronchiolitis","officialTitle":"Nebulized Hypertonic Saline for Treatment of Viral Bronchiolitis","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2008-02","primaryCompletion":"2011-05","completion":"2011-05","firstPosted":"2008-02-21","resultsPosted":"2013-10-10","lastUpdate":"2024-11-05"},"enrollment":447,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Bronchiolitis"],"interventions":[{"type":"DRUG","name":"Nebulized 3% saline","otherNames":["3% saline","Hypertonic saline","NaCl 3%"]},{"type":"DRUG","name":"Nebulized 0.9% saline","otherNames":["Normal saline","NS","NaCl 0.9%"]}],"arms":[{"label":"Nebulized 3% Saline","type":"EXPERIMENTAL"},{"label":"Nebulized 0.9% Saline","type":"PLACEBO_COMPARATOR"}],"summary":"This study aims to examine the effect of nebulized 3% hypertonic saline in the treatment of viral bronchiolitis. The investigators hypothesize that nebulized 3% saline will decrease rate of hospital admission, decrease clinical severity scores, and decrease length of stay.","primaryOutcome":{"measure":"Admission Rate","timeFrame":"1 day","effectByArm":[{"arm":"Hypertonic Saline","deltaMin":55,"sd":null},{"arm":"Normal Saline","deltaMin":76,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":6},"locations":{"siteCount":2,"countries":["United States"]},"refs":{"pmids":["24862623"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":231},"commonTop":["ICU admission","Worsening cough"]}}